These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15134245)

  • 1. [Pharmaceutical and non-pharmaceutical therapeutics. Regulation and recommendations].
    Bouvenot G; Villani P
    Rev Prat; 2004 Feb; 54(3):331-8, 330. PubMed ID: 15134245
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacologic and non-pharmacologic treatments. Legal rules].
    Bouvenot G; Villani P; Bouvenot J; Ambrosi P
    Rev Prat; 2010 Oct; 60(8):1165-72. PubMed ID: 21197760
    [No Abstract]   [Full Text] [Related]  

  • 3. Generics market in Greece: the pharmaceutical industry's beliefs.
    Geitona M; Zavras D; Hatzikou M; Kyriopoulos J
    Health Policy; 2006 Nov; 79(1):35-48. PubMed ID: 16386326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Medical prescriptions in haemodialysis patients: critical analysis].
    Riemer E; Werling E; Kribs M; Hamman De Compte A; Dimitrov Y
    Nephrol Ther; 2005 Oct; 1(4):234-40. PubMed ID: 16895690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Health economics evaluations are of great significance for Pharmaceutical Benefit Board's decisions].
    Persson U; Ramsberg J
    Lakartidningen; 2007 Oct 17-23; 104(42):3046-50. PubMed ID: 17985712
    [No Abstract]   [Full Text] [Related]  

  • 6. Physicians' opinions and experiences of the Pharmaceutical Benefits Reform.
    Andersson K; Jörgensen T; Carlsten A
    Scand J Public Health; 2006; 34(6):654-9. PubMed ID: 17132599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dispensing drugs].
    Montloin A
    Rev Infirm; 1989 Dec; 39(20):27-31. PubMed ID: 2485947
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prescriptions in international common denomination drugs, a future headache for nurses?].
    Maisonneuve C
    Soins; 2002 Nov; (670):7-8. PubMed ID: 12465367
    [No Abstract]   [Full Text] [Related]  

  • 9. [Reimbursement of drug expenses--unseen problem, increasing threats].
    Lukawiecki K
    Kardiol Pol; 2006 Jul; 64(7):767-9; discussion 770. PubMed ID: 16886139
    [No Abstract]   [Full Text] [Related]  

  • 10. Increasing generic drug use in Medicare Part D: the role of government.
    Kohl H; Shrank WH
    J Am Geriatr Soc; 2007 Jul; 55(7):1106-9. PubMed ID: 17608887
    [No Abstract]   [Full Text] [Related]  

  • 11. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic aspects of the new Spanish laws on pharmaceutical preparations.
    Antoñanzas F; Oliva J; Pinillos M; Juàrez C
    Eur J Health Econ; 2007 Sep; 8(3):297-300. PubMed ID: 17401592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valuable information regarding generic drugs. Cutting costs by going generic.
    J Am Vet Med Assoc; 2004 Oct; 225(8):1168. PubMed ID: 15521435
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prescription by INN (International Non-Proprietary Name)].
    Elsen C; Nève J; Schetgen M
    J Pharm Belg; 2005; 60(3):77-83. PubMed ID: 16252508
    [No Abstract]   [Full Text] [Related]  

  • 15. Generic drugs in cardiology: will they reduce health care costs?
    Pitt B
    J Am Coll Cardiol; 2004 Jul; 44(1):10-3. PubMed ID: 15234397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Generic name or brand name?].
    Madsen S
    Tidsskr Nor Laegeforen; 2006 Feb; 126(4):431. PubMed ID: 16477277
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug committees should not recommend "off label" prescriptions].
    Rane A
    Lakartidningen; 2006 Apr 12-25; 103(15-16):1219. PubMed ID: 16696203
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prescription of drugs without approval to be commercialized].
    Bégué D
    Ann Chir Plast Esthet; 2004 Feb; 49(1):49-60. PubMed ID: 15013536
    [No Abstract]   [Full Text] [Related]  

  • 19. [Generic drug substitution].
    Tamir O; Halkin H; Shemer J
    Harefuah; 2006 Sep; 145(9):691-5, 701. PubMed ID: 17078434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Policies concerning pharmaceutical prices and reimbursement in Mexico, Organization for Co-operation and Economic Development. 2007].
    Moïse P; Docteur E
    Salud Publica Mex; 2008; 50 Suppl 4():S504-10. PubMed ID: 19082262
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.